An Epigenetic Approach to Pancreatic Cancer Treatment: The Prospective Role of Histone Deacetylase Inhibitors

Publisher： Bentham Science Publishers

E-ISSN： 1873-5576|12|4|439-452

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.12, Iss.4, 2012-04, pp. : 439-452

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Progress in the Discovery of Macrocyclic Histone Deacetylase Inhibitors for the Treatment of Cancer

By  

Current Medicinal Chemistry, Vol. 24, Iss. 37, 2017-12 ,pp. : 4166-4179

Bentham Science Publishers

Access to resources Recommend Favorite

Histone Deacetylase Inhibitors for the Treatment of Colorectal Cancer: Recent Progress and Future Prospects

By  

Current Cancer Drug Targets, Vol. 17, Iss. 5, 2017-05 ,pp. : 456-466

Bentham Science Publishers

Access to resources Recommend Favorite

Histone Methyltransferase Inhibitors: Novel Epigenetic Agents for Cancer Treatment

By  

Current Medicinal Chemistry, Vol. 20, Iss. 2, 2013-01 ,pp. : 167-185

Bentham Science Publishers

Access to resources Recommend Favorite

Role of Histone Deacetylases and Their Inhibitors in Cancer Biology and Treatment

By  

Current Clinical Pharmacology, Vol. 5, Iss. 3, 2010-08 ,pp. : 196-208

Bentham Science Publishers

Access to resources Recommend Favorite

Next generation histone deacetylase inhibitors: the answer to the search for optimized epigenetic therapies?

By Thaler Florian   Minucci Saverio  

Expert Opinion on Drug Discovery, Vol. 6, Iss. 4, 2011-04 ,pp. : 393-404

Informa Healthcare

Access to resources Recommend Favorite